Shares of small modular (nuclear) power plant-builder NuScale Power (NYSE: SMR) stock tumbled 9.3% through 11:45 a.m. ET Wednesday. You can blame Wall Street analyst TD Cowen for that. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » Image source: Getty Images. TD kicks NuScale to the curb This morning, you see, TD Cowen analyst Marc Bianchi downgraded NuScale stock from buy to hold, ...

Upgrades - BMO Capital upgraded Southwest (LUV) to Outperform from Market Perform with a price target of $57.50, up from $43, citing significant momentum and earnings upside to at least $4.00 per share in 2026 from 93 cents in 2025 [2] - Barclays upgraded Quest Diagnostics (DGX) to Overweight from Equal Weight with a price target of $210, up from $195, noting sustainable organic growth of 4% from fiscal 2024 to 2025 [3] - Guggenheim upgraded GE Vernova (GEV) to Buy from Neutral with a price target of $910, believing the market may underestimate cash generation potential and margin improvement in the electrification segment [4] - Wolfe Research upgraded Broadcom (AVGO) to Outperform from Peer Perform with a price target of $400, based on channel checks indicating the company will ship 7 million tensor processing units by 2028 [5] - Citi upgraded Spotify (SPOT) to Buy from Neutral with an unchanged price target of $650, stating the stock's valuation is now attractive and consensus estimates are beatable [5] Downgrades - HSBC downgraded Pinterest (PINS) to Hold from Buy with a price target of $24.90, down from $34.50, due to an abrupt jobs cut announcement indicating a softer near-term outlook [6] - Jefferies downgraded Kenvue (KVUE) to Hold from Buy with a price target of $18, down from $23, following shareholder approval for a merger with Kimberly-Clark [6] - Citizens downgraded SAP (SAP) to Market Perform from Outperform without a price target, citing disappointing Q4 sales results and a current cloud backlog growth of 25% versus the expected 26% [6] - D. Boral Capital downgraded Quince Therapeutics (QNCX) to Hold from Buy without a price target after negative results from a pivotal Phase 3 clinical trial [6] - Stifel downgraded Codere Online (CDRO) to Hold from Buy with a price target of $8.50, down from $9, believing the company's estimates need to reset due to a recently announced tax hike in Mexico [6]

Upgrades - CoStar Group (CSGP) upgraded to Buy from Neutral with an $80 price target due to low expectations, past peak investment, and momentum from Homes.com, along with an anticipated AI-driven product update [2] - Teleflex (TFX) upgraded to Buy from Hold with a $138 price target as the company plans to sell its acute care, interventional urology, and manufacturing businesses for $2 billion, expecting significant earnings accretion from share repurchases and debt repayment by 2027 [3] - CoreWeave (CRWV) upgraded to Buy from Hold with a $140 price target, with a solid medium-term outlook ahead of the Q4 report [3] - Affirm (AFRM) upgraded to Buy from Hold with a $100 price target after submitting an application to establish Affirm Bank, which could be a game-changer [4] - Target (TGT) upgraded to Peer Perform from Underperform without a price target, with a wide margin of safety despite reduced estimates due to the company's owned real estate [4] Downgrades - Procter & Gamble (PG) downgraded to Hold from Buy with a price target of $156, up from $150, as the pace of recovery is expected to drag [5] - Stryker (SYK) downgraded to Hold from Buy with a $387 price target following a transfer in analyst coverage, with a well-understood valuation reflecting a "beat/raise precedent" [5] - Insulet (PODD) downgraded to Hold from Buy with a $294 price target after a transfer in analyst coverage, noting that competitive advantages may narrow [5] - Matador (MTDR) downgraded to Equal Weight from Overweight with a price target of $47, down from $61, due to stock valuation incorporating structural considerations and recent productivity variability [5] - SkyWater Technology (SKYT) downgraded to Hold from Buy with a price target of $35, up from $24, after agreeing to be acquired by IonQ for $35 per share or $1.88 billion [5]

Core Viewpoint - Ermenegildo Zegna's stock experienced a significant decline of over 13% following a downgrade from Bank of America Securities, reflecting investor concerns about the company's future prospects [1]. Group 1: Recommendation Changes - Bank of America Securities analyst Daria Nasledysheva downgraded Zegna's recommendation from buy to hold, adjusting the price target from $11.50 to $11.20 per share [2]. - The downgrade indicates a shift in sentiment regarding Zegna's growth potential and market performance [2]. Group 2: Company Strategy and Performance - Nasledysheva views Zegna as a successful turnaround story, noting its transition from formalwear to luxury leisurewear [3]. - Concerns were raised about the potential underperformance of Zegna's Thom Browne and Tom Ford brands, which may hinder overall growth [3]. - The company faces challenges in increasing margins, particularly in light of recent changes in its executive leadership [3]. Group 3: Executive Changes - At the beginning of the year, Zegna implemented several executive changes, with Gildo Zegna stepping down as CEO while remaining chairman, and Gianluca Tagliabue taking over as CEO [4]. - The transition in leadership is still in its early stages, but initial observations suggest it is proceeding smoothly [5]. Group 4: Current Financial Metrics - Zegna's current stock price is $9.56, with a market capitalization of $2.8 billion [5]. - The stock has a gross margin of 55.55% and a dividend yield of 1.28% [5]. - The trading volume for the day was 2.2 million shares, with an average volume of 569,000 shares [5].

Core Viewpoint - Sigma Lithium's stock has experienced a significant decline, dropping over 14% recently due to operational challenges and downgrades from analysts, leading investors to sell off their shares [1][3]. Group 1: Stock Performance - Sigma Lithium shares fell 12.9% as of 11:41 a.m. ET, indicating a continued downward trend [1]. - The stock was downgraded from buy to hold by Canaccord, reflecting a bearish outlook [3]. Group 2: Operational Challenges - The Brazilian Labor Ministry has shut down three waste piles at Sigma Lithium's Grota do Cirilo asset, citing risks to workers and the community [4]. - Sigma Lithium announced a pause in operations at Mine 1, Grota do Cirilo, with a projected resumption by the end of November 2025 [5]. Group 3: Analyst Sentiment - Bank of America assigned a price target of $14 for Sigma Lithium stock, indicating a negative outlook [3]. - Analysts suggest that investors should consider other lithium stocks that present less risk until uncertainties around Grota do Cirilo are resolved [5][6].

Core Viewpoint - EOG Resources, Inc. is facing a cautious outlook from analysts and some institutional investors, despite continued interest from others in the energy sector [2][3][4]. Group 1: Analyst Ratings - KeyBanc downgraded EOG from an Overweight rating to a Sector Weight rating on January 15, 2026, indicating potential challenges ahead for the stock [2]. - The downgrade occurred when EOG's stock price was $108.02, suggesting a shift in sentiment towards a more conservative view [2]. Group 2: Institutional Investor Activity - Conning Inc. reduced its stake in EOG by 8.7% during the third quarter, selling 26,399 shares, which left them with 277,163 shares valued at approximately $31 million [3]. - In contrast, Alliancebernstein L.P. increased its stake by 4.2% in the second quarter, acquiring an additional 249,984 shares, totaling over 6.1 million shares valued at $737 million [4]. - Invesco Ltd. also expanded its holdings by 7.0%, now owning over 4.4 million shares, indicating some institutional confidence in EOG's future performance [4]. Group 3: Stock Performance - EOG's stock has recently declined by approximately 2.46%, with a trading range between $107.42 and $110.16 [5]. - Over the past year, the stock has fluctuated significantly, reaching a high of $137.86 and a low of $101.59 [5]. - EOG's market capitalization is approximately $58.98 billion, with a trading volume of 3,241,987 shares, indicating active investor interest [5].

Group 1 - Shares of the solar panel manufacturer were downgraded to Hold from Buy at Jefferies [1]

Upgrades - Keefe Bruyette upgraded Bain Capital Specialty Finance (BCSF) to Outperform from Market Perform with an unchanged price target of $16, citing attractive entry point for shares [2] - JPMorgan upgraded Paccar (PCAR) to Overweight from Neutral with a price target of $133, increased from $108, due to offsetting tariff-related headwinds following the latest Section 232 proclamation [3] - Wells Fargo upgraded Generac (GNRC) to Overweight from Equal Weight with a price target of $195, up from $186, highlighting a "near-free call option" on data center growth after recent share pullback [4] - Barclays upgraded Cummins (CMI) to Overweight from Equal Weight with a price target of $546, increased from $515, reflecting new emissions rules and reduced R&D expenses [5] - Citizens upgraded Stryker (SYK) to Outperform from Market Perform with a price target of $440, citing reasonable valuation at current share levels [5] Downgrades - Wedbush downgraded Lyft (LYFT) to Underperform from Neutral with a price target of $16, down from $20, due to risks from autonomous vehicle disruption in the U.S. ridesharing market [6] - JPMorgan downgraded Lockheed Martin (LMT) to Neutral from Overweight with a price target of $515, up from $465, based on out-year cash flow estimates being below consensus [6] - Raymond James downgraded Allegiant Travel (ALGT) to Outperform from Strong Buy with a price target of $98, up from $78, citing valuation concerns after recent share strength [6] - Deutsche Bank downgraded Elevance Health (ELV) to Hold from Buy with a price target of $320, down from $332, due to reduced estimates and challenging macro environment [6] - Williams Trading downgraded Birkenstock (BIRK) to Hold from Buy with a price target of $51, down from $75, following earnings report and lack of clarity from management [6]

Core Viewpoint - AkzoNobel has been downgraded to a "Market Perform" rating by Bernstein, reflecting a challenging financial outlook for the company [1][2][5] Company Performance - AkzoNobel's stock price is currently $20.88, showing a 2.24% increase or $0.46 from previous trading [3][5] - The stock has fluctuated between $20.57 and $20.88 on the day, with a yearly high of $24.52 and a low of $18.07 [3] - The company's market capitalization is approximately $32.14 billion, with a trading volume of 5,257 shares on the OTC exchange [3][5] Earnings Outlook - AkzoNobel has been added to the Zacks Rank 5 (Strong Sell) List, indicating a negative sentiment in the market [2][4][5] - There has been a 10.1% downward revision in the Zacks Consensus Estimate for the company's current year earnings over the past 60 days [2][5] - The inclusion in the Strong Sell List aligns with broader market challenges, as seen with other companies like Alvotech and Alamo Group, which also experienced significant downward revisions in earnings estimates [4]

Upgrades - JPMorgan upgraded Outfront Media (OUT) to Overweight from Neutral with a price target of $25, up from $19, citing the out-of-home channel as the most resilient traditional advertising market with improved momentum in Q3 [2] - Guggenheim upgraded Grail (GRAL) to Buy from Neutral with a price target of $100, noting that while Galleri is not a perfect test, it remains the leading commercially available MCED test with a significant data moat [3] - Piper Sandler upgraded Floor & Decor (FND) to Overweight from Neutral with a price target of $80, up from $75, highlighting potential for comparable sales improvement by Q1 of 2026 [4] - KeyBanc upgraded Progyny (PGNY) to Overweight from Sector Weight with a price target of $30, indicating limited share downside and several positive catalysts over the next 12 months [4] - KeyBanc upgraded AT&T (T) to Overweight from Sector Weight with a price target of $30, attributing the recent share pullback to overblown wireless competition concerns [5] Downgrades - Raymond James downgraded Bath & Body Works (BBWI) to Market Perform from Outperform, stating that the company's growth will be below its long-term potential due to slow improvements in digital capabilities and distribution [6] - Wolfe Research downgraded Intellia Therapeutics (NTLA) to Peer Perform from Outperform, citing safety issues with nexiguran ziclumeran as a hindrance to the bull thesis [6] - Raymond James double downgraded Brighthouse Financial (BHF) to Market Perform from Strong Buy, referencing the announcement of its acquisition deal for $70 per share [6] - Raymond James double downgraded Centerspace (CSR) to Market Perform from Strong Buy, noting that while the portfolio is attractive for potential buyers, the recent rally has closed the valuation gap with multifamily peers [6] - Northland downgraded QuickLogic (QUIK) to Market Perform from Outperform, maintaining a price target of $5.95, after the company reported revenue in line with guidance and uncertainty regarding a $3M contract [6]